{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BNO 1016", "antibiotics", "herbal medicine", "phytotherapy", "sinusitis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37431675", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1080/00325481.2023.2234274"], "Journal": {"ISSN": "1941-9260", "JournalIssue": {"Volume": "135", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Aug"}}, "Title": "Postgraduate medicine", "ISOAbbreviation": "Postgrad Med"}, "ArticleTitle": "Efficacy and effectiveness of the herbal medicinal product BNO 1016 in the management of acute rhinosinusitis in the context of antibiotic stewardship.", "Pagination": {"StartPage": "607", "EndPage": "614", "MedlinePgn": "607-614"}, "Abstract": {"AbstractText": ["To substantiate the clinical efficacy and investigate the real-world effectiveness of the herbal medicinal product BNO 1016 in acute rhinosinusitis (ARS) in the context of antibiotic stewardship.", "We performed a meta-analysis of the clinical trials ARhiSi-1 (EudraCT No. 2008-002794-13) and ARhiSi-2 (EudraCT No. 2009-016682-28) comprising 676 patients, analyzing the reduction of the Major Symptom Score (MSS) and improvement of the Sino-Nasal Outcome Test 20 (SNOT-20) by the herbal medicinal product BNO 1016. In addition, we performed a retrospective cohort study including 203,382 patients, comparing the real-life effectiveness of BNO 1016 in reducing ARS-related adverse outcomes in comparison to antibiotics and several other established therapies.", "Treatment with BNO 1016 ameliorated symptoms of ARS by reducing MSS by 1.9 points (<i>p</i>\u2009<\u20090.0001) and improved quality of life (QoL) for patients by improving SNOT-20 by 3.5 points (<i>p</i>\u2009=\u20090.001) in comparison to placebo. In patients with moderate/severe symptoms, the positive effects of BNO 1016 were even more pronounced (MSS: -2.3 points (<i>p</i>\u2009<\u20090.0001); SNOT-20: -4.9 points (<i>p</i>\u2009=\u20090.0158)). In addition, treatment with BNO 1016 was as effective or significantly more effective in reducing the risk for adverse ARS-related outcomes such as follow-up antibiotic prescriptions, sick leave\u2009\u22657\u2009days or medical appointments due to ARS, especially when compared to antibiotics.", "BNO 1016 is a safe and effective treatment for ARS that can help reduce the overuse of antibiotics."]}, "AuthorList": [{"Identifier": ["0000-0002-7641-0351"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research & Development, Bionorica SE, Neumarkt i. d. OPf, Germany."}], "LastName": "Bittner", "ForeName": "Claudia B", "Initials": "CB"}, {"Identifier": ["0000-0002-7195-5061"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research & Development, Bionorica SE, Neumarkt i. d. OPf, Germany."}], "LastName": "Steindl", "ForeName": "Hubert", "Initials": "H"}, {"Identifier": ["0000-0002-8293-9403"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research & Development, Bionorica SE, Neumarkt i. d. OPf, Germany."}], "LastName": "Abramov-Sommariva", "ForeName": "Dimitri", "Initials": "D"}, {"Identifier": ["0000-0003-4507-1227"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research & Development, Bionorica SE, Neumarkt i. d. OPf, Germany."}], "LastName": "Plach", "ForeName": "Michael", "Initials": "M"}, {"Identifier": ["0000-0002-7778-7740"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research & Development, Bionorica SE, Neumarkt i. d. OPf, Germany."}], "LastName": "Abels", "ForeName": "Christoph", "Initials": "C"}, {"Identifier": ["0000-0003-4742-1665"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Otorhinolaryngology, Head and Neck Surgery, University of Muenster, Muenster, Germany."}], "LastName": "Bachert", "ForeName": "Claus", "Initials": "C"}], "PublicationTypeList": ["Meta-Analysis", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Postgrad Med", "NlmUniqueID": "0401147", "ISSNLinking": "0032-5481"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "BNO 1016"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": [], "DescriptorName": "Antimicrobial Stewardship"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Rhinitis"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Sinusitis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2023", "Month": "8", "Day": "23", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "11", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "11", "Hour": "5", "Minute": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37431675", "10.1080/00325481.2023.2234274"]}}], "PubmedBookArticle": []}